Abstract
Congenital polycythemias have diverse etiologies, including mutations in the hypoxia sensing pathway. These include HIF2A at exon 12, VHL gene (Chuvash polycythemia), and PHD2 mutations, which in one family was also associated with recurrent pheochromocytoma/paraganglioma (PHEO/PGL). Over the past two decades, we have studied seven unrelated patients with sporadic congenital polycythemia who subsequently developed PHEO/PGL with, until now, no discernible molecular basis. We now report a polycythemic patient with a novel germline HIF2A F374Y (exon 9) mutation, inherited from his mother, who developed PHEO/PGL. We show that this is a gain-of-function mutation and demonstrate no loss-of-heterozygosity or additional somatic mutation of HIF2A in the tumor, indicating HIF2A F374Y may be predisposing rather than causative of PHEO/PGL. This report, in view of two other concomitantly reported PHEO/PGL patients with somatic mutations of HIF2A and polycythemia, underscores the PHEO/PGL-promoting potential of mutations of HIF2A that alone are not sufficient for PHEO/PGL development.
Similar content being viewed by others
References
Prchal JT (2003) Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis. Hematol Oncol Clin North Am 17:1151–1158, vi
Semenza GL (2001) HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167–171
Wang GL, Semenza GL (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90:4304–4308
Percy MJ, Furlow PW, Lucas GS, Li X, Lappin TR, McMullin MF, Lee FS (2008) A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med 358:162–168
Ang SO, Chen H, Gordeuk VR, Sergueeva AI, Polyakova LA, Miasnikova GY, Kralovics R, Stockton DW, Prchal JT (2002) Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis 28:57–62
Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D et al (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614–621
Pastore Y, Jedlickova K, Guan Y, Liu E, Fahner J, Hasle H, Prchal JF, Prchal JT (2003) Mutations of von Hippel–Lindau tumor-suppressor gene and congenital polycythemia. Am J Hum Genet 73:412–419
Percy MJ, Furlow PW, Beer PA, Lappin TR, McMullin MF, Lee FS (2007) A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood 110:2193–2196
Ladroue C, Hoogewijs D, Gad S, Carcenac R, Storti F, Barrois M, Gimenez-Roqueplo AP, Leporrier M, Casadevall N, Hermine O et al (2012) Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia. Haematologica 97:9–14
Tian H, McKnight SL, Russell DW (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72–82
Semenza GL (2009) Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24:97–106
Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC (2007) Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104:2301–2306
Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, Prchal JT (2006) Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 281:25703–25711
Yoon D, Ponka P, Prchal JT (2011) Hypoxia. 5. Hypoxia and hematopoiesis. Am J Physiol Cell Physiol 300:C1215–C1222
Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148:399–408
Semenza GL (2007) HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 39:231–234. doi:10.1007/s10863-007-9081-2
Schimke RN, Collins DL, Stolle CA (1993) Von Hippel–Lindau syndrome. Bookshelf ID: NBK1463 [bookaccession]
Friedrich CA (2001) Genotype-phenotype correlation in von Hippel–Lindau syndrome. Hum Mol Genet 10:763–767
Richards FM, Webster AR, McMahon R, Woodward ER, Rose S, Maher ER (1998) Molecular genetic analysis of von Hippel–Lindau disease. J Intern Med 243:527–533
Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, Losman JA, Joensuu P, Bergmann U, Gross S et al (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483:484–488
Erbel PJ, Card PB, Karakuzu O, Bruick RK, Gardner KH (2003) Structural basis for PAS domain heterodimerization in the basic helix–loop–helix-PAS transcription factor hypoxia-inducible factor. Proc Natl Acad Sci U S A 100:15504–15509
LLC M ICM 3.4 Manual (http://www.molsoft.com) For energy minimization, docking and molecular dynamics calculations. Molsoft LLC, San Diego
Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K (2012) Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 367:922–930
Kralovics R, Sokol L, Prchal JT (1998) Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. J Clin Invest 102:124–129
Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, Feunteun J, Pouyssegur J, Richard S, Gardie B (2008) PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med 359:2685–2692
Acknowledgments
JTP is supported by NIH-P01CA108671, VA Merit Review Award and University of Utah Seed Grant Program for studies of hypoxic adaptation. MG is supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (#1006407). KP, ZZ, CY, and TH are supported, in part, by the Intramural Research Program of the NIH, NICHD, and NINDS.
Conflict of interest
Authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Karel Pacak and Josef T. Prchal are senior authors.
Rights and permissions
About this article
Cite this article
Lorenzo, F.R., Yang, C., Ng Tang Fui, M. et al. A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med 91, 507–512 (2013). https://doi.org/10.1007/s00109-012-0967-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-012-0967-z